AZN IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN

Core Viewpoint - Rosen Law Firm is reminding investors who purchased AstraZeneca PLC securities between February 23, 2022, and December 17, 2024, about the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased AstraZeneca securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 21, 2025 [3] - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] Group 2: Case Allegations - The lawsuit alleges that AstraZeneca made materially false and misleading statements, including engaging in insurance fraud in China and facing heightened legal exposure as a result [5] - The allegations suggest that AstraZeneca understated its legal risks, which could materially harm its business activities in China once revealed [5]